Clinical trial
A Phase II Study of Sorafenib in Patients With Metastatic Renal Cell Carcinoma
NCT00445042 is registered in ClinicalTrials.gov with The Methodist Hospital Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Sorafenib in Patients With Metastatic Renal Cell Carcinoma
- Lead sponsor
- The Methodist Hospital Research Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2005
- Completion date
- October 31, 2008
- Enrollment
- 71 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.